The U.S. Food and Drug Administration is conducting a national listening tour to meet directly with pharmaceutical and biotech CEOs. Held in major innovation hubs across the country, the CEO Forums will be led by FDA Commissioner Marty A. Makary, M.D., M.P.H., along with Principal Deputy Commissioner Sara Brenner, M.D., M.P.H and Director of FDA’s Center for Biologics Evaluation and Research, Vinay Prasad, M.D., M.P.H.  

These forums are part of a new initiative to gather direct input from biotechnology and pharmaceutical leaders on how the FDA can modernize its regulatory framework to better support innovation and patient access to safe and effective therapies.

Please use the registration form below to express your interest in attending one of the CEO forums being held across the country.  

Requirements

• Registrants must have at least one active Investigational New Drug (IND), New Drug Application (NDA) or Biologics License Application (BLA) on file with the FDA.
• While participation by a CEO is preferred, registration is also open to the company's CEO or a Chief Medical Officer or Head of Research and Development.  
• Interested companies should only register for one CEO Forum.
• Final eligibility for attendance will be determined by the FDA.

https://www.fda.gov/industry/ceo-forums-fda-listening-tour-engage-pharma-ceos